(Q24246968)

5

object named as

ZA Bhutta

0 references

author name string

D Thaver

1

0 references

AK Zaidi

2

0 references

SA Madni

Cochrane Database of Systematic Reviews

4

0 references

publication date

20 April 2005

0 references

published in

0 references

cites work

A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

Ciprofloxacin treatment failure in typhoid fever case, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

Typhoid fever in Bangladesh: implications for vaccination policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Comparison of two regimens for ciprofloxacin treatment of enteric infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Pefloxacin versus chloramphenicol in the therapy of typhoid fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Ciprofloxacin in typhoid fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Randomized treatment of patients with typhoid and paratyphoid fevers using norfloxacin or chloramphenicol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

A randomized comparative study of fleroxacin and ceftriaxone in enteric fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Short courses of ofloxacin for the treatment of enteric fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Experts call for surveillance of drug-resistant typhoid at a global level.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Ciprofloxacin-resistant Salmonella typhi in the UK.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Typhoid fever in children aged less than 5 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Re-emergence of chloramphenicol-sensitive Salmonella typhi.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Ciprofloxacin versus chloramphenicol in the treatment of salmonella infection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Fluoroquinolones in paediatrics: a risk for the patient or for the community?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

1 reference

7 January 2021

Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Enteric fever in Mumbai, India: the good news and the bad news.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Ciprofloxacin resistance in Salmonella paratyphi A.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Management of typhoid fever in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Fluoroquinolones: considerations for future use.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Impact of age and drug resistance on mortality in typhoid fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Fluoroquinolone adverse effects and drug interactions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Fleroxacin vs Ciprofloxacin in the Management of Typhoid Fever: A Randomised, Open, Comparative Study in Nigerian Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Drug-resistant Salmonella enterica serotype paratyphi A in India

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004530.PUB2

7 January 2021

10.1002/14651858.CD004530.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1369625

OpenCitations bibliographic resource ID

1369625

1 reference